Leading Article Biologicals & Immunologicals: Immunological adjuvants: Mechanisms of action and clinical applications
Authors:
- 1 September 1996
- journal article
- Published by Informa Healthcare in Expert Opinion on Investigational Drugs
- Vol. 5 (9) , 1079-1099
Abstract
Adjuvants are a neglected aspect of vaccine formulations, prudent choice of which can enhance the immune response both quantitatively and qualitatively. This review details the evolution and current range of adjuvants, particularly those in clinical trials. The components of different adjuvants are outlined and the manner in which they are thought to work is discussed. Antigen processing is an essential requirement of any immune response and these mechanisms are discussed in the context of adjuvant action.Keywords
This publication has 27 references indexed in Scilit:
- T Helper Cell SubsetsClinical Immunotherapeutics, 1995
- Trimming of TAP-translocated peptides in the endoplasmic reticulum and in the cytosol during recycling.Journal of Experimental Medicine, 1994
- Defective major histocompatibility complex class II assembly, transport, peptide acquisition, and CD4+ T cell selection in mice lacking invariant chain expression.Journal of Experimental Medicine, 1993
- Efficient dissociation of the p88 chaperone from major histocompatibility complex class I molecules requires both beta 2-microglobulin and peptide.Journal of Experimental Medicine, 1992
- Liposomal malaria vaccine in humans: a safe and potent adjuvant strategy.Proceedings of the National Academy of Sciences, 1992
- Phagocytosis of liposomes by macrophages: intracellular fate of liposomal malaria antigenBiochimica et Biophysica Acta (BBA) - Biomembranes, 1991
- A Formalin-Inactivated Whole SIV Vaccine Confers Protection in MacaquesScience, 1989
- Contact sensitivity to aluminiumContact Dermatitis, 1986
- SINGLE-DOSE ANTENATAL TETANUS IMMUNISATIONThe Lancet, 1973
- Immunological notes. XVII–XXIVThe Journal of Pathology and Bacteriology, 1926